SCHEMBL6991083

SCHEMBL6991083

CSc1ncnc(CN2CCN(CC=Cc3ccccc3)CC2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
LMNA P02545 8/20 0.49
KMT2A Q03164 5/20 0.49
MEN1 O00255 3/20 0.49
TSHR P16473 6/20 0.45
HTT P42858 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 2/20 0.45
GAA P10253 4/20 0.44
MAPK1 P28482 3/20 0.44
CYP3A4 P08684 2/20 0.44
HIF1A Q16665 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
GMNN O75496 1/20 0.44
ABCB11 O95342 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310015 0.83 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL6310022 0.83 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL2579539 0.73 LMNA (0.72) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL8558370 0.72 ALDH1A1 (0.53) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL5961390 0.69 SIGMAR1 (0.75) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL14045655 0.69 ALDH1A1 (0.63) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL27580427 0.69 ALDH1A1 (0.63) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL11036914 0.67 LTA4H (0.77) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL613704 0.67 LTA4H (0.77) ALDH1A1LMNAKMT2AMEN1TSHR
SCHEMBL16226425 0.66 SMN1; SMN2 (0.62) ALDH1A1LMNAKMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341773-A2 SUBSTITUTED 1,3,5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2003-09-10 EP disclosed
WO-2002046172-A2 SUBSTITUTED 1, 3, 5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2002-06-13 WO disclosed